Evidence map›Paper›PMID 32508168›Full record

ReviewThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2022

Effectiveness and safety of available treatments for COVID-19 during pregnancy: a critical review.

Alessandro Favilli, Marta Mattei Gentili, Francesca Raspa, Irene Giardina, Fabio Parazzini, Amerigo Vitagliano, Anna V Borisova, Sandro Gerli

Abstract readReview
In one paragraph

Review in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Pregnancy and COVID-19.Journal of clinical medicine · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Managing COVID-19 in pregnant women.Breathe (Sheffield, England) · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Focusing Treatment on Pregnant Women With COVID Disease.Frontiers in global women's health · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alessandro FavilliDepartment of Obstetrics and Gynecology, AOUI Verona, Verona, Italy.ORCID 0000-0002-1556-0962
Marta Mattei GentiliDepartment of Surgical and Biochemical Sciences, Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy.
Francesca RaspaDepartment of Surgical and Biochemical Sciences, Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy.
Irene GiardinaDepartment of Surgical and Biochemical Sciences, Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy.
Fabio ParazziniFondazione IRCCS Cà Granda, Dipartimento Materno-Infantile, Ospedale Maggiore Policlinico, Università degli Studi di Milano, Dipartimento di Scienze Cliniche e di Comunità, Universita' di Milano, Milan, Italy.ORCID 0000-0001-5624-4854
Amerigo VitaglianoDepartment of Women's and Children's Health, University of Padua, Padova, Italy.
Anna V BorisovaDepartment of Obstetrics and Gynecology with the Course of Perinatology, Peoples Friendship University of Russia (RUDN University), Moscow, Russian Federation.ORCID 0000-0003-4716-2886
Sandro GerliDepartment of Surgical and Biochemical Sciences, Centre of Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy.ORCID 0000-0003-1082-3062

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 is a pandemic disease caused by the SARS-CoV-2 and it spread globally in the last few months. The complete lack of specific treatment forced clinicians to use old drugs, chosen for their efficacy against similar viruses or their

methodsWe reviewed all the available literature concerning the drugs that have been used in the treatment of COVID-19 during pregnancy and whose safe assumption during pregnancy had been demonstrated by clinical studies (i.e. including studies on other infectious diseases). Drugs contra-indicated during pregnancy or with unknown adverse effects were not included in our review. RESULTS AND

conclusionsClinical trials are not often conducted among pregnant patients for safety reasons and this means that drugs that may be effective in general population cannot be used for pregnant women due to the lack of knowledge of side effects in this category of people .The choice to use a specific drug for COVID-19 in pregnancy should take into account benefits and possible adverse events in each single case. In the current situation of uncertainty and poor knowledge about the management of COVID-19 during pregnancy, this present overview may provide useful information for physicians with practical implications.

Indexed as

COVID-19 Drug TreatmentPregnancy Complications, InfectiousFemaleHumansPandemicsPregnancyPregnant PeopleSARS-CoV-2COVID-19pregnancySARS-CoV-2therapy

Identifiers

PMID32508168
PMCPMC7284138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.